Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Cash from Operations (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Cash from Operations for 8 consecutive years, with 11250000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 39.78% to 11250000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 65843000.0 through Dec 2025, down 12.66% year-over-year, with the annual reading at 65843000.0 for FY2025, 12.66% down from the prior year.
  • Cash from Operations for Q4 2025 was 11250000.0 at Precision Biosciences, up from 15270000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 68072000.0 in Q1 2021, with the low at 31464000.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 13250400.0, with a median of 19661500.0 recorded in 2025.
  • The sharpest move saw Cash from Operations skyrocketed 362.72% in 2021, then tumbled 179.12% in 2023.
  • Over 5 years, Cash from Operations stood at 23681000.0 in 2021, then grew by 7.76% to 21843000.0 in 2022, then skyrocketed by 61.44% to 8423000.0 in 2023, then plummeted by 121.81% to 18683000.0 in 2024, then skyrocketed by 39.78% to 11250000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 11250000.0, 15270000.0, and 20271000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.